16h agoPolicy proposal outlines 'Innovation Review Vouchers' for 90-day US drug approvals and transferable exclusivityThe program grants up to three years of exclusivity.SentimentSentimentPos100%Neg0%Users endorse the proposal for innovation review vouchers to accelerate US drug approvals and boost biotech competitiveness, viewing it as a non-obvious objective idea that could include stronger incentives like zero capital gains on R&D.2 comments with sentiment. View comments.